Splitting hairs or not: importance of N2 subclassification after neoadjuvant treatment and surgery COMMENT

被引：0
|
作者：
Chan, Joyce W. Y. [1 ]
Lau, Rainbow W. H. [1 ]
Ng, Calvin S. H. [1 ]
机构：
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Div Cardiothorac Surg, Hong Kong, Peoples R China
来源：
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY | 2022年 / 61卷 / 02期
关键词：
Skip N2; Lung cancer; Neoadjuvant; Persistent N2; CELL LUNG-CANCER; CHEMOTHERAPY;
D O I：
10.1093/ejcts/ezab473
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：277 / 278
页数：2
相关论文
共 50 条
  • [1] FDG PET/CT for assessing the resectability of NSCLC patients with N2 disease after neoadjuvant therapy
    Kremer, Ran
    Peysakhovich, Yury
    Dan, Levy-Faber
    Guralnik, Ludmila
    Kagna, Olga
    Nir, Rony-Reuven
    Bar-Shalom, Rachel
    ANNALS OF NUCLEAR MEDICINE, 2016, 30 (02) : 114 - 121
  • [2] Where is the Place of Surgery for N2 Disease?
    Van Schil, Paul
    Faivre-Finn, Corinne
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S152 - S154
  • [3] Is Surgery Worthwhile in Locally-advanced NSCLC Patients with Persistent N2-disease After Neoadjuvant Therapy?
    Lococo, Filippo
    Chiappetta, Marco
    Sassorossi, Corolina
    Nachira, Dania
    Evangelista, Jessica
    Ciavarella, Leonardo Petracca
    Congedo, Maria Teresa
    Porziella, Venanzio
    Boldrini, Luca
    Larici, Annarila
    Bria, Emilio
    Margaritora, Stefano
    REVIEWS ON RECENT CLINICAL TRIALS, 2022, 17 (02) : 103 - 108
  • [4] Thoracoscopic Vs Open Surgery Following Neoadjuvant Chemoradiation for Clinical N2 Lung Cancer
    Jeon, Yeong Jeong
    Choi, Yong Soo
    Cho, Jong Ho
    Kim, Hong Kwan
    Kim, Jhingook
    Zo, Jae Ill
    Shim, Young Mog
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2022, 34 (01) : 300 - 308
  • [5] The Role of Surgery in Patients with Clinical N2 Disease
    Mehran, Reza
    THORACIC SURGERY CLINICS, 2013, 23 (03) : 327 - +
  • [6] Surgery for Pancreatic Cancer after neoadjuvant treatment
    Hackert, Thilo
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2018, 2 (06): : 413 - 418
  • [7] Surgery for stage III N2 non-small cell lung cancer within multimodal treatment concepts Novel neoadjuvant and adjuvant treatment strategies
    Eichhorn, Florian
    Eichhorn, Martin
    ONKOLOGIE, 2022, 28 (12): : 1059 - 1064
  • [8] Lung Cancer: Is Surgery an Option for Persisting N2 after Induction Therapy?
    Haager, B.
    Osei-Agyemang, T.
    Passlick, B.
    Wiesemann, S.
    ZENTRALBLATT FUR CHIRURGIE, 2015, 140 (01): : 99 - 103
  • [9] Advances in the use of surgery and multimodality treatment for N2 non-small cell lung cancer
    Van Schil, Paul E.
    Yogeswaran, Krishan
    Hendriks, Jeroen M.
    Lauwers, Patrick
    Faivre-Finn, Corinne
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (06) : 555 - 561
  • [10] Breast surgery after neoadjuvant treatment. Is it necessary?
    Mumtaz, H
    Davidson, T
    Spittle, M
    Tobias, J
    HallCraggs, MA
    Cowley, G
    Taylor, I
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1996, 22 (04): : 335 - 341
12345